Examkin

Soru

Zorluk: ZorGynecologic Infections

Following a presentation of severe, bilateral lower pelvic pain and high-grade fever (38.9∘C38.9^\circ\text{C}), a 3232-year-old female is evaluated in the emergency department. She reports having a copper intrauterine device (IUD) inserted four years prior. On physical examination, marked cervical motion tenderness and purulent cervical exudate are noted. Pelvic ultrasonography confirms the IUD is properly situated within the endometrial cavity and reveals bilateral fallopian tube thickening consistent with severe pelvic inflammatory disease (PID), but no tubo-ovarian abscess is visualized. The patient is admitted to the inpatient ward for complicated PID.

Arrange the following diagnostic and therapeutic interventions in the most appropriate chronological sequence according to current clinical guidelines.

  1. 1Obtain a cervical swab for Neisseria gonorrhoeae and Chlamydia trachomatis nucleic acid amplification testing (NAAT).
  2. 2Initiate empiric parenteral antimicrobial therapy with ceftriaxone, doxycycline, and metronidazole.
  3. 3Maintain the intrauterine device in place while closely observing for clinical improvement over the next 48 to 72 hours.
  4. 4Remove the intrauterine device if the patient experiences persistent symptoms and a lack of clinical improvement.

Cevap

The correct sequence of management for severe PID with an IUD in place begins with obtaining diagnostic NAAT swabs, followed immediately by initiating empiric parenteral antibiotics. The IUD should be left in place while the patient is monitored for clinical improvement over 48 to 72 hours. IUD removal is only indicated as a subsequent step if the patient fails to improve on the antibiotic regimen.
The standard of care for a patient presenting with severe pelvic inflammatory disease (PID) and an intrauterine device (IUD) follows a strict evidence-based sequence. First, diagnostic swabs (NAAT) must be collected to guide targeted therapy. Immediately following collection, empiric parenteral antibiotics are initiated because delaying treatment increases the risk of infertility. Crucially, the IUD should not be removed upon initial diagnosis. The patient must be monitored for 48 to 72 hours on parenteral therapy. IUD removal is reserved only for patients who fail to demonstrate clinical improvement (e.g., defervescence, reduction in pain) after this initial observation period.

Adım Adım Çözüm

1
Collect cervical swabs for NAAT.
Pathogen identification is initiated.
Cultures and NAAT must be obtained before antibiotics rapidly sterilize the sample, ensuring targeted antimicrobial stewardship.
2
Administer broad-spectrum intravenous antibiotics.
Treatment for severe PID is commenced.
Empiric therapy must begin promptly to prevent severe complications like tubal scarring and ectopic pregnancy.
3
Observe the patient with the IUD remaining in situ for 48 to 72 hours.
Initial response to parenteral therapy is assessed.
Guidelines explicitly advise against immediate IUD removal; most patients respond successfully to antibiotics with the IUD in place.
4
Remove the IUD if there is clinical failure after the observation period.
Source control is achieved in a non-responding patient.
Failure to improve indicates the foreign body is likely preventing clearance of the infection, necessitating its removal.

Anahtar Kavram

Management of Pelvic Inflammatory Disease in patients with an Intrauterine Device
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru